Metabolite of MS drug could be safe, effective therapy for Parkinson’s
Wednesday, June 8, 2016 - 12:21
in Health & Medicine
The metabolite of a drug that is helping patients battle multiple sclerosis appears to significantly slow the onset of Parkinson’s disease, researchers say. The oral drug, dimethylfumarate, or DMF, and its metabolite, monomethylfumarate, or MMF, both increase activity of Nrf2, a protein that helps protect the body from oxidative stress and inflammation, hallmarks of both […]